Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.84 USD | -0.25% | -0.87% | +34.04% |
09-09 | Analyst recommendations: Verizon, Nucor, Colgate-Palmolive, Kimberly-Clark... | |
09-09 | Deutsche Bank Downgrades Colgate-Palmolive to Hold, Price Target is $109 | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 15.69B | 16.47B | 17.42B | 17.97B | 19.46B | |||||
Total Revenues | 15.69B | 16.47B | 17.42B | 17.97B | 19.46B | |||||
Cost of Goods Sold, Total | 6.36B | 6.45B | 7.05B | 7.72B | 8.13B | |||||
Gross Profit | 9.34B | 10.02B | 10.38B | 10.25B | 11.33B | |||||
Selling General & Admin Expenses, Total | 5.62B | 6.1B | 6.48B | 6.62B | 7.24B | |||||
Other Operating Expenses | 106M | 136M | 67M | 19M | 148M | |||||
Other Operating Expenses, Total | 5.72B | 6.23B | 6.54B | 6.64B | 7.38B | |||||
Operating Income | 3.61B | 3.79B | 3.83B | 3.6B | 3.94B | |||||
Interest Expense, Total | -192M | -183M | -192M | -167M | -287M | |||||
Interest And Investment Income | 47M | 19M | 17M | 14M | 55M | |||||
Net Interest Expenses | -145M | -164M | -175M | -153M | -232M | |||||
Income (Loss) On Equity Invest. | 9M | 12M | 12M | 12M | 17M | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 3.48B | 3.64B | 3.67B | 3.46B | 3.73B | |||||
Restructuring Charges | -132M | 16M | - | -110M | -32M | |||||
Merger & Related Restructuring Charges | -24M | -6M | - | -19M | - | |||||
Impairment of Goodwill | - | - | -367M | -332M | - | |||||
Gain (Loss) On Sale Of Investments | -51M | - | -10M | - | -11M | |||||
Gain (Loss) On Sale Of Assets | - | - | - | 47M | - | |||||
Asset Writedown | - | - | -204M | -389M | - | |||||
Legal Settlements | 30M | - | - | - | -267M | |||||
Other Unusual Items | - | - | - | - | -25M | |||||
EBT, Incl. Unusual Items | 3.3B | 3.65B | 3.09B | 2.66B | 3.39B | |||||
Income Tax Expense | 774M | 787M | 749M | 693M | 937M | |||||
Earnings From Continuing Operations | 2.53B | 2.86B | 2.34B | 1.97B | 2.46B | |||||
Extraordinary Item & Accounting Change | - | - | - | - | - | |||||
Net Income to Company | 2.53B | 2.86B | 2.34B | 1.97B | 2.46B | |||||
Minority Interest | -160M | -165M | -172M | -182M | -155M | |||||
Net Income - (IS) | 2.37B | 2.7B | 2.17B | 1.78B | 2.3B | |||||
Net Income to Common Incl Extra Items | 2.37B | 2.7B | 2.17B | 1.78B | 2.3B | |||||
Net Income to Common Excl. Extra Items | 2.37B | 2.7B | 2.17B | 1.78B | 2.3B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.76 | 3.15 | 2.56 | 2.13 | 2.78 | |||||
Basic EPS - Continuing Operations | 2.76 | 3.15 | 2.56 | 2.13 | 2.78 | |||||
Basic Weighted Average Shares Outstanding | 859M | 857M | 845M | 836M | 827M | |||||
Net EPS - Diluted | 2.75 | 3.14 | 2.55 | 2.13 | 2.77 | |||||
Diluted EPS - Continuing Operations | 2.75 | 3.14 | 2.55 | 2.13 | 2.77 | |||||
Diluted Weighted Average Shares Outstanding | 861M | 859M | 848M | 839M | 829M | |||||
Normalized Basic EPS | 2.34 | 2.46 | 2.51 | 2.37 | 2.63 | |||||
Normalized Diluted EPS | 2.34 | 2.45 | 2.5 | 2.36 | 2.62 | |||||
Dividend Per Share | 1.71 | 1.75 | 1.79 | 1.86 | 1.91 | |||||
Payout Ratio | 62.23 | 55.73 | 77.52 | 94.73 | 76.04 | |||||
American Depositary Receipts Ratio (ADR) | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | |||||
Supplemental Items | ||||||||||
EBITDA | 4.1B | 4.33B | 4.39B | 4.15B | 4.51B | |||||
EBITA | 3.68B | 3.88B | 3.92B | 3.68B | 4.01B | |||||
EBIT | 3.61B | 3.79B | 3.83B | 3.6B | 3.94B | |||||
EBITDAR | 4.3B | 4.51B | 4.56B | 4.31B | 4.67B | |||||
Effective Tax Rate - (Ratio) | 23.45 | 21.58 | 24.26 | 26.05 | 27.62 | |||||
Normalized Net Income | 2.01B | 2.11B | 2.12B | 1.98B | 2.17B | |||||
Interest Capitalized | 1M | 1M | 3M | 5M | 12M | |||||
Non-Cash Pension Expense | 59M | 21M | 12M | 34M | 341M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 1.69B | 1.95B | 2.02B | 2B | 2.37B | |||||
Selling and Marketing Expenses | 1.69B | 1.95B | 2.02B | 2B | 2.37B | |||||
Research And Development Expense From Footnotes | 281M | 290M | 307M | 320M | 343M | |||||
Net Rental Expense, Total | 204M | 178M | 168M | 160M | 157M | |||||
Imputed Operating Lease Interest Expense | 42.4M | 31.38M | 32.62M | 25.71M | 40.96M | |||||
Imputed Operating Lease Depreciation | 162M | 147M | 135M | 134M | 116M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 100M | 107M | 135M | 125M | 122M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 100M | 107M | 135M | 125M | 122M |